Merit Medical Systems (MMSI) Liabilities and Shareholders Equity (2010 - 2026)
Merit Medical Systems (MMSI) reported Liabilities and Shareholders Equity of $2.7 billion for Q1 2026, up 10.18% on a YoY basis from $2.5 billion in Q1 2025, and up 1.24% sequentially from $2.7 billion in Q4 2025.
Merit Medical Systems (MMSI) Liabilities and Shareholders Equity (2010 - 2026) Analysis & Trends
Merit Medical Systems (MMSI) has 17 years of Liabilities and Shareholders Equity data on file, last reported at $2.7 billion in Q1 2026.
- For the quarter ending Q1 2026, Liabilities and Shareholders Equity rose 10.18% year-over-year to $2.7 billion; the trailing twelve-month figure through Mar 2026 stood at $10.6 billion (up 10.23% YoY), and the FY2025 full-year result was $2.7 billion, up 11.05% from the prior year.
- Liabilities and Shareholders Equity climbed to $2.7 billion in Q1 2026, from $2.7 billion in the prior quarter.
- In the past five years, Liabilities and Shareholders Equity ranged from a high of $2.7 billion in Q1 2026 to a low of $1.6 billion in Q1 2022.
- A 5-year average of $2.2 billion and a median of $2.3 billion in 2024 frame the typical range for Liabilities and Shareholders Equity.
- Across the five-year window, Liabilities and Shareholders Equity fell 1.33% in 2022 and soared 39.74% in 2023, its largest moves.
- Tracing MMSI's Liabilities and Shareholders Equity over 5 years: stood at $1.7 billion in 2022, then surged by 39.74% to $2.3 billion in 2023, then climbed by 4.02% to $2.4 billion in 2024, then gained by 11.05% to $2.7 billion in 2025, then grew by 1.24% to $2.7 billion in 2026.
- Business Quant data shows MMSI's Liabilities and Shareholders Equity at $2.7 billion in Q1 2026, $2.7 billion in Q4 2025, and $2.6 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 31.62 Bn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 20.88 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 50.83 Bn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 39.01 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 8.78 Bn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 4.08 Bn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 12.48 Bn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 14.10 Bn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 6.31 Bn |
| 10 | Merit Medical Systems | 4.36 Bn | 3.87 Bn | 184.80 Mn | 2.72 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.72 Bn |
| Dec 31, 2025 | 2.69 Bn |
| Sep 30, 2025 | 2.63 Bn |
| Jun 30, 2025 | 2.59 Bn |
| Mar 31, 2025 | 2.47 Bn |
| Dec 31, 2024 | 2.42 Bn |
| Sep 30, 2024 | 2.38 Bn |
| Jun 30, 2024 | 2.37 Bn |
| Mar 31, 2024 | 2.33 Bn |
| Dec 31, 2023 | 2.33 Bn |
| Sep 30, 2023 | 1.81 Bn |
| Jun 30, 2023 | 1.84 Bn |
| Mar 31, 2023 | 1.68 Bn |
| Dec 31, 2022 | 1.66 Bn |
| Sep 30, 2022 | 1.63 Bn |
| Jun 30, 2022 | 1.63 Bn |
| Mar 31, 2022 | 1.63 Bn |
| Dec 31, 2021 | 1.65 Bn |
| Sep 30, 2021 | 1.64 Bn |
| Jun 30, 2021 | 1.64 Bn |